Luo Jinquan, Li Yueming, Lin Jielin, Li Xinyi, He Wang, Yuan Runqiang, Gong Mancheng
Department of Urology, The People's Hospital of Zhongshan, Zhongshan, Guangdong, China.
Department of Urology, Sun Yat-sen Memorial Hospital, Guangzhou, Guangdong, China.
Front Surg. 2025 Aug 7;12:1628264. doi: 10.3389/fsurg.2025.1628264. eCollection 2025.
This study aimed to compare the efficacy and safety of two tip-flexible suctioning ureteral access sheaths (TFS-UAS), 12/14Fr (Group A) and 10/12Fr (Group B), combined with a 7.5Fr flexible ureteroscope (f-URS) for treating upper ureteral and renal stones.
A retrospective analysis of 168 patients undergoing retrograde intrarenal surgery (RIRS) was conducted. Group A ( = 76) used a 12/14Fr TFS-UAS, while Group B ( = 92) used a 10/12Fr TFS-UAS. Primary outcomes included stone-free rates (SFR) (Grade I: ≤2 mm; Grade II: ≤4 mm fragments), operative times, and complications.
Baseline characteristics were comparable between groups. Group A demonstrated significantly shorter operation (72.5 vs. 78.5 min, < 0.05) and lithotripsy durations (57.5 vs. 64.5 min, < 0.05). Immediate SFR (Grade I) was higher in Group A (86.8% vs. 71.7%, = 0.018), but 1-month SFR showed no difference (90.8% vs. 84.4%, = 0.242). Grade II SFR and complication rates (ureteric injury, fever, sepsis) were similar ( > 0.05).
The 12/14Fr TFS-UAS combined with a 7.5Fr f-URS offers superior lithotripsy efficiency and immediate SFR compared to the 10/12Fr variant, while maintaining comparable long-term outcomes and safety. These findings support its clinical preference for RIRS in upper tract calculi.
本研究旨在比较两种头端可弯曲的输尿管鞘(TFS-UAS),即12/14Fr(A组)和10/12Fr(B组),联合7.5Fr可弯曲输尿管镜(f-URS)治疗上段输尿管结石和肾结石的疗效及安全性。
对168例行逆行肾内手术(RIRS)的患者进行回顾性分析。A组(n = 76)使用12/14Fr TFS-UAS,而B组(n = 92)使用10/12Fr TFS-UAS。主要结局指标包括结石清除率(SFR)(I级:≤2 mm;II级:≤4 mm碎片)、手术时间和并发症。
两组间基线特征具有可比性。A组的手术时间(72.5 vs. 78.5分钟,P < 0.05)和碎石时间(57.5 vs. 64.5分钟,P < 0.05)明显更短。A组的即刻SFR(I级)更高(86.8% vs. 71.7%,P = 0.018),但1个月时的SFR无差异(90.8% vs. 84.4%,P = 0.242)。II级SFR和并发症发生率(输尿管损伤、发热、脓毒症)相似(P > 0.05)。
与10/12Fr型号相比,12/14Fr TFS-UAS联合7.5Fr f-URS具有更高的碎石效率和即刻SFR,同时保持了相当的长期疗效和安全性。这些发现支持其在治疗上段尿路结石的RIRS中具有临床优势。